News and Resources
Phlow Corp. CFO Receives Virginia Business CFO Award
Phlow is honored to announce that our CFO, Bob Mooney, has received the coveted Virginia Business CFO Award honoring chief financial executives in Virginia.
Phlow Corporation Donates to Pleasants Lane Elementary in Petersburg
Phlow Corporation was honored to present, alongside our partners, AMPAC Fine Chemicals, Civica Rx, and Virginia Commonwealth University Medicines For All Institute, a check for over $58,000 on June 17, 2021 to Pleasants Lane Elementary in Petersburg, Virginia to rebuild their playground.
Phlow Corporation Supports Biden Administration Efforts to Strengthen the Pharmaceutical Supply Chain
The pieces of a Petersburg pharmaceuticals hub continue to fall into place.
Pharma Venture Fuels $25M Expansion of AMPAC Facility in Petersburg
The pieces of a Petersburg pharmaceuticals hub continue to fall into place.
Pharmaceutical Ingredients Maker Plans $25 million Expansion at its Petersburg Plant, Adding 156 New Jobs
A manufacturer of pharmaceutical ingredients in Petersburg is planning a $25 million expansion of its operations that is expected to add 156 new jobs.
Governor Northam Announces AMPAC Fine Chemicals to Expand Petersburg Operation with $25 Million Investment, Adding 156 New Jobs
Pharmaceutical manufacturer is a collaborator in new government-funded partnership to produce essential medications
Shortages of Key Drugs for Children Spur New Hospital Coalition
Source: Bloomberg In Washington, just four miles from the U.S. Capitol, a children’s hospital is forced at times to call up nearby medical centers to see if they can spare the therapies needed for its young cancer patients. In Chicago, a drug called epinephrine, which...
Leading Children’s Hospitals and Phlow Corp. Form an Unprecedented Coalition to Deliver Essential Medicines to Address Pediatric Drug Shortages
RICHMOND, Va., March 18, 2021 – Phlow Corp., a U.S.-based, public benefit corporation committed to a bold mission of providing every American with access to affordable, high-quality essential medicines, today joins in announcing the launch of a groundbreaking...
Phlow Corp. and USP Announce Strategic Alliance Focused on Pharmaceutical Continuous Manufacturing to Increase Supply of Essential Medicines for U.S. Patients
Phlow and the United States Pharmacopeia have formed a strategic alliance to develop a new laboratory that will certify and validate Pharmaceutical Continuous Manufacturing processes resulting in affordable, high-quality, U.S.-manufactured essential medicines.
Phlow Corp. Closes $20 Million Series A Financing to Further Essential Medicines Research and Development Programs and Advanced Manufacturing Initiatives
This injection of additional strategic capital will further enhance Phlow’s mission to reimagine the end-to-end domestic production critical to U.S. healthcare.